2.5 mg semaglutide equivalent to tirzepatide Subcutaneously administered vs for adults with type 2 diabetes: a systematic review and network meta-analysis of randomised controlled trials | Diabetologia Switching Semaglutide to Tirzepatide: A

Semaglutide is a medication originally developed for type 2 diabetes that is now increasingly used for weight management due to its proven benefits on appetite control and metabolism

Neurosci Lett 349 : 7578 Tang-Christensen M et al

Exposure to sugars induces rapid GLP-1 secretion from T1R3-sensitive cells, following a dose-dependent pattern where higher stimulus concentrations lead to greater secretionan effect blocked by GLP-1 receptor antagonists (61, 67)

Ulcerative colitis is one such novel research target for GLP-1 analogs

2729 Furthermore, strategies targeting the modulation of the gut microbiota (eg, probiotics and fecal microbiota transplantation) as well as exogenous supplementation with SCFAs have been widely proposed as potential therapeutic approaches, offering new avenues for mechanism-based interventions